ACOR Acorda Therapeutics Inc

Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/10/2006
Outstanding shares:  11,202,242
Average volume:  230,198
Market cap:   $24,751,155
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00484M601
ISIN:        US00484M6012
Valuation   (See tab for details)
PE ratio:   -0.17
PB ratio:   0.17
PS ratio:   0.19
Return on equity:   -101.19%
Net income %:   -127.77%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy